Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Finished Goods (2016 - 2025)

CV Sciences' Finished Goods history spans 12 years, with the latest figure at $1.3 million for Q3 2025.

  • On a quarterly basis, Finished Goods rose 10.4% to $1.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.3 million, a 10.4% increase, with the full-year FY2024 number at $1.7 million, up 5.37% from a year prior.
  • Finished Goods hit $1.3 million in Q3 2025 for CV Sciences, down from $1.3 million in the prior quarter.
  • Over the last five years, Finished Goods for CVSI hit a ceiling of $3.3 million in Q4 2021 and a floor of $1.2 million in Q3 2024.
  • Historically, Finished Goods has averaged $2.0 million across 5 years, with a median of $1.7 million in 2024.
  • Biggest five-year swings in Finished Goods: tumbled 40.27% in 2022 and later increased 13.41% in 2024.
  • Tracing CVSI's Finished Goods over 5 years: stood at $3.3 million in 2021, then tumbled by 40.27% to $2.0 million in 2022, then fell by 20.1% to $1.6 million in 2023, then rose by 5.37% to $1.7 million in 2024, then dropped by 22.92% to $1.3 million in 2025.
  • Business Quant data shows Finished Goods for CVSI at $1.3 million in Q3 2025, $1.3 million in Q2 2025, and $1.4 million in Q1 2025.